Published: January 31, 2019

Introduction {#sec1}
============

Cellular plasticity is an important feature within adult organs facilitating rapid adaptation of progenitors to injury or environmental changes. Previously, it was thought that progenitors within organs would respond to injury in a uni-directional cell lineage manner. A series of differentiation steps producing multiple cell intermediates, each with a more restricted lineage potential than the last, would eventually lead to specialized cells. Recent reports challenge this paradigm showing that cells can acquire characteristics of other cell types beyond their proposed lineage ([@bib33]) by converting into earlier cell types (de-differentiation), more distant phenotypes (trans-differentiation), or interchange between different progenitors (trans-determination). Each of these three cellular processes may occur in different settings and to various degrees ([@bib10]). Interestingly, both cell-autonomous and non-cell-autonomous mechanisms are proposed to contribute to this plasticity. Environmental factors, such as cell-cell contact or ligand presentation, contribute to non-cell-autonomous induction. Whereas transcription factors (TFs) are part of the autonomous mechanism, playing a major role in regulating cell fate, stability, and conversion. However, very little is known about how plasticity is regulated, and how it varies among cell types and different conditions.

Exocrine glands, such as the mammary, lacrimal, and salivary glands, all share a similar secretory function that entails production and secretion of milk, tears, and saliva, respectively ([@bib36]). They all undergo branching morphogenesis to create a ductal tree structure distally ending in secretory units whereby fluid can be produced, modified, transported, and released from the gland. These secretory units include secretory acinar cells, associated intercalated ducts that connect larger ducts to the acini, and contractile myoepithelial cells surrounding the acini ([@bib20]). As such, it was postulated that various signaling pathways and cellular mechanisms must overlap among these exocrine glands ([@bib36]). For example, the TF MIST1 was identified as a "scaling factor" to induce and maintain the secretory cell architecture of mature acinar cells in multiple exocrine tissues ([@bib19]). However, which specific TFs control and direct epithelial progenitors to form the secretory units, and whether common TFs are involved in different organs are unknown.

TFs whose activity is necessary and sufficient to direct specific cell lineage commitment, and that can also re-specify the fate of cells destined to become other lineages, are termed core master regulators ([@bib5]). Master regulators promote gene transcription to initiate or maintain the desired cell fate, and repress gene expression that oppose this decision; ultimately stabilizing cell fate decisions. Here we identify *Sox10* as a master regulator to maintain and direct KIT^+^ progenitors into secretory units of exocrine glands. SOX proteins have previously been described as mediators of both stemness and cell differentiation ([@bib1]), and *Sox10* is well-known for its role in neural crest stem cell maintenance and their differentiation into oligodendrocytes and glia cells ([@bib30]). Surprisingly, more recent studies reported SOX10 in epithelial cell types of exocrine mammary, lacrimal, and salivary glands ([@bib8], [@bib11], [@bib21]). Using salivary glands as our primary model system, we report that *Sox10* is an exocrine gland-specific core master regulator that is sufficient to induce plasticity and multi-potency of tissue-specific progenitors to form functional secretory units.

Results {#sec2}
=======

The KIT/FGFR2b-*Sox10* Axis Defines Initial Tissue-Specific Cells {#sec2.1}
-----------------------------------------------------------------

To identify tissue-specific progenitors, we analyzed protein expression of known markers of adult and fetal salivary submandibular gland (SMG) progenitors. Adult SMG progenitors expressing CD117 (KIT, c-Kit) were previously shown to regenerate radiation-damaged mouse SMGs *in vivo* by differentiating into saliva-secreting acinar and saliva-transporting duct cells ([@bib22]). However, their presence and function at SMG ontogenesis (embryonic day 11.5 \[E11.5\]) remained unclear. SMGs, such as the parotid (PAR) and sublingual (SLG) salivary glands, derive from an invagination and thickening of oral epithelium ([@bib15]). This thickened epithelium forms a single endbud, termed cap or tip cells in other exocrine glands, which clefts to generate multiple distal endbuds on a lengthening proximal duct. We found that KIT^+^ cells are present at SMG initiation, as protein staining of enzymatically isolated epithelia from E11.5--E12 embryos showed membrane localization of KIT on the oral epithelial lining, initial single SMG endbud, and main duct ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). By E13, however, KIT expression becomes restricted to endbuds only ([Figure S1](#mmc1){ref-type="supplementary-material"}A) ([@bib21]). These KIT^+^ progenitors require FGFR2b signaling for cell survival, cell proliferation, and initiation of SOX10 expression to become uniquely distinct from the SOX2^+^KIT^−^ main ducts ([@bib21], [@bib23]). Thus, as oral epithelial cells express KIT at gland initiation, we hypothesized that KIT/FGFR2b-regulated TFs specify the initial tissue-specific progenitors. We show that, during the initial oral budding, SOX10^+^ cells are localized in the distal epithelia while proximal layers expressed SOX2^+^ ([Figures 1](#fig1){ref-type="fig"}A--1C). Sporadically, a SOX2^+^SOX10^+^ cell was found at the border of both cell layers ([Figure 1](#fig1){ref-type="fig"}C, arrows), suggesting a potential transitioning cell. The oral epithelium is known to express *Sox2*, *ΔNp63*, *Fgfr2b*, and intracellular cytokeratins KRT14 (K14) and KRT5 (K5) ([@bib14], [@bib31]). Protein analysis of KRT\'s in E11.5--E12 isolated epithelia revealed two distinct layers, in a similar manner to SOX2 and SOX10 expression. Proximal cells co-expressed K14, K5, and K19, while distal cells were enriched for K14^+^ ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). SOX2 expression overlapped with K14^+^K5^+^ proximal cells and SOX10 was co-expressed in K14^+^ distal cells ([Figure S1](#mmc1){ref-type="supplementary-material"}D); confirming the positioning of two distinct epithelial layers at SMG ontogenesis.Figure 1The KIT/FGFR2b-*Sox10* Axis Defines Initial Tissue-Specific Cells(A) Confocal images of E11.5, E12, and E13 isolated SMG epithelia stained for SOX10 and KIT. Scale bars, 20 μm.(B) E11.5 isolated epithelium stained for SOX10 and SOX2. Scale bars, 20 μm.(C) SOX10 and SOX2 expression in E11.5 epithelium. Arrows outline SOX10^+^SOX2^+^. Scale bars, 20 μm.(D and E) Confocal images of E16 LG, E16 PAR, E13 SLG, and E16 MMG. Tissue was stained for SOX10, SOX2, and KIT, or K14, K5, and K19. Scale bars, 100 μm (D) and 20 μm (E).

To investigate the role of FGFR2b signaling in specifying the tissue-specific distal epithelial progenitors, we analyzed the initiating glands of *Fgf10*^*−/−*^ murine embryos, which lack the ligand for FGFR2b and die at birth due to severe abnormalities in multiple organs. E11.5 *Fgf10*^*−/−*^ isolated SMG epithelia expressed SOX2 but failed to express SOX10, even though surrounding neuronal cells (CDH1/E-cadherin-negative) clearly expressed SOX10 ([Figure S1](#mmc1){ref-type="supplementary-material"}E, arrow). As FGF10/FGFR2b signaling is the primary signal to initiate *Sox10*^*+*^ cells, we isolated and cultured wild-type E12 epithelia for 2 h in basal medium +/− FGF10. Within this time frame, *Sox2* expression was downregulated and *Sox10* was upregulated ([Figure S1](#mmc1){ref-type="supplementary-material"}F), suggesting that FGF10/FGFR2b signaling induces the switch from SOX2^+^ into SOX10^+^ cells.

To confirm that the KIT/FGFR2b-*Sox10* axis was important in other exocrine glands, we evaluated distal cells in lacrimal, PAR, SLG, and mammary glands (MMGs). The SLG was the only exception where SOX2 was expressed in distal KIT^+^ cells. The other exocrine glands exclusively expressed KIT and SOX10 ([Figure 1](#fig1){ref-type="fig"}D), and all salivary glands shared a similar epithelial KRT-expressing cell population ([Figure 1](#fig1){ref-type="fig"}E).

Thus, we identified two distinct KIT^+^ epithelial cell layers present at SMG initiation: proximal SOX2^+^ oral epithelial cells and distal SOX10^+^ cells that initiate in an *Fgf10*-dependent manner. Collectively, these data suggest that SOX10 defines the initial endbud cells of exocrine glands.

Glandular Tissues Originate from Oral Epithelial *Sox2* Cells {#sec2.2}
-------------------------------------------------------------

To elucidate the contribution of SOX2^+^ oral epithelial and SOX10^+^ cells to tissue formation, we used lineage tracing to visualize their progeny. *Sox2*-Cre mice crossed with *Rosa26*-^*flox*^mTomato^*flox*^-mGFP (mTmG) mice showed that the SMG is mGFP^+^, demonstrating that SMGs are offspring of *Sox2* cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A). This is consistent with data that SOX2 is first expressed by pluripotent embryonic stem cells at E2.5--E3.5, and thus expected to give rise to all glands ([@bib3]). Next, tamoxifen-inducible *Sox2*-Cre mice allowed us to specifically track progeny of E9--E11 oral epithelial cells. Consistent with previous literature ([@bib32], [@bib35]), we found that all (E13) epithelial cells, including SOX10^+^ cells, arose from E9 to E11 *Sox2* oral epithelia ([Figure 2](#fig2){ref-type="fig"}A). The E9--E11 *Sox2* cells also contributed to epithelial cells in adult SMGs, as well as their inter-glandular ducts, which connect the organ to the oral cavity ([Figure 2](#fig2){ref-type="fig"}B, arrows). Inter-glandular ducts are comprised of two types of ducts that transport saliva outside the organ: excretory ducts (EDs) that connect with one main Wharton\'s duct (WD, SMG) or Bartholin\'s duct (BD, SLG).Figure 2Initial Tissue-Specific SOX10^+^ Cells Are Multi-potent ProgenitorsSox2-Cre™ or Sox10-Cre mice were crossed with Rosa26-mTmG mice for lineage tracing. mGFP^+^ (mG) cells are lineage-derived cells, mTomato (mT) cells are not.(A and B) E9--E11 induced lineage tracing seen in isolated E13 epithelia (A) or adult SMG (B). E13 epithelium was co-stained with SOX10. Scale bars: (A, left and B, left) 100 μm; (A, right and B, right) 20 μm. WD, SMG Wharton\'s duct; BD, SLG Bartholin\'s duct. Arrows outline mG^+^ cells.(C) Confocal images of E16 SMG with WD, and SLG with BD. Tissue was lineage traced from E12--13. Scale bar, 100 μm.(D) Isolated epithelia were analyzed by confocal microscopy at E12 and E13. E13 epithelium was co-stained for SOX10. Scale bars, 100 μm (left and middle) and 20 μm (right).(E) Confocal imaging of adult SMG intra-glandular striated ducts (SD), inter-glandular excretory ducts (EDs) and WDs. Arrowheads and arrows represent mT and mG epithelial cells, respectively. Acinar cell (Ac), intercalated duct (ID). Scale bars, 20 μm (left) and 200 μm (centers and right).(F) Graphical cartoon depicting the presence of two epithelial cell types after E11.5 SMG initiation: SOX2^+^ oral epithelial cells co-expressing K14, K5, and K19, and distal SOX10^+^ tissue-specific SMG cells solely co-expressing K14. Both cell types express KIT and FGFR2b, but contribute differentially to adult glands. Once tissue-specific cells are formed, oral epithelial cells only contribute to parts of the inter-glandular ducts connecting the secretory organ with the oral cavity. Instead, *Sox10* cells form all epithelial cells in the adult SMG, as well cells parts in inter-glandular ducts.

We hypothesized that SOX2^+^ oral epithelial cells would not contribute to organ formation after initiation of the SOX10^+^ cells in the distal endbud. Indeed, induction of *Sox2*-Cre at E12--E13, after SMG initiation, supported our hypothesis, as *Sox2* cells no longer contributed to SMG development ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}B). In addition, the intra-glandular ducts, such as striated ducts (SD), were mGFP-negative. However, various portions of the larger inter-glandular ducts as well as cells in SLGs did derive from E12 to E13 *Sox2*^*+*^ cells ([Figure S2](#mmc1){ref-type="supplementary-material"}B, arrows). This result supports our previous data that basal cells in the main duct of developing SMGs remain SOX2^+^ ([@bib24]), and that SOX2 is present in distal cells of SLGs ([Figure 1](#fig1){ref-type="fig"}D). These data thus suggest that all salivary glandular tissue is derived from the *Sox2*^+^ oral epithelium at E9--E11, but thereafter more restricted tissue-specific progenitor cell contributes to organ development.

The Initial *Sox10*^+^ Cells Are Multi-potent Progenitors of Secretory Units {#sec2.3}
----------------------------------------------------------------------------

We next investigated the contribution of *Sox10* epithelial cells during development. Lineage tracing with a constitutive *Sox10*-Cre mouse confirmed the unique location of SOX10^+^ cells in distal epithelial endbuds (E12--E13) ([Figure 2](#fig2){ref-type="fig"}D). Up to 99.9% ± 0.1% and 98.3% ± 0.6% of all myoepithelial and acinar cells were *Sox10*-derived ([Figure S2](#mmc1){ref-type="supplementary-material"}C), respectively, as quantified by co-expression with mGFP in adult *Sox10*-Cre mice. On the other hand, cells of the inter-glandular ducts (EDs and WDs) were not entirely *Sox10* derived, and these non-*Sox10*-derived offspring became more prominent in the WD ([Figure 2](#fig2){ref-type="fig"}E, arrowheads). Interestingly, distal parts of these inter-glandular ducts, were *Sox10* derived ([Figure 2](#fig2){ref-type="fig"}E, arrows), suggesting that inter-glandular ducts may be derived from both oral epithelium and SOX10^+^ cells. This pattern was apparent during development (E14) where distal parts of the duct remain *Sox10*^+^ ([Figure S2](#mmc1){ref-type="supplementary-material"}D). However, adult intra-glandular epithelia were exclusively mGFP^+^ ([Figure 2](#fig2){ref-type="fig"}E), which could be observed by co-staining with an epithelial marker K8, myoepithelial marker alpha-smooth muscle actin (ACTA2), and acinar cell-specific water channel aquaporin5 (AQP5) ([Figure S2](#mmc1){ref-type="supplementary-material"}D). In fact, the parenchyma and inter-glandular ducts of adult lacrimal and PAR glands were also entirely *Sox10* derived ([Figure S2](#mmc1){ref-type="supplementary-material"}E), while the SLG epithelial cells were both *Sox2* and *Sox10* derived. When *Sox10*-rtTA;*Tet*-Cre mice were induced at E9--12, the analysis confirmed the exclusive contribution of the initial *Sox10* cells to adult SMG organ formation. The acinar (84.3% ± 1.2%), myoepithelial (85.4% ± 4.1%) and ductal (97.3% ± 4.5%) cells co-expressed mGFP, suggesting that initial *Sox10* cells form the entire SMG epithelium ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Taken together, these data identify *Sox10* as an early marker of multi-potent tissue-specific epithelial progenitors of exocrine glands ([Figure 2](#fig2){ref-type="fig"}F).

Loss in *Sox10* Reduces Exocrine Gland Development {#sec2.4}
--------------------------------------------------

We next identified mechanisms through which *Sox10* regulates cellular processes. There was ∼64% overlapping protein expression of SOX10 with CCND1 or KI67 in distal E13 KIT^+^ progenitors, suggesting that *Sox10* could regulate cell proliferation ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). At E16, secretory cell differentiation begins and KIT^+^ progenitors could lose potency by either downregulating *Sox10* or becoming quiescent. Quantification of SOX10 and/or CCND1 in E16 KIT^+^ progenitors indicated that SOX10 remained highly expressed in proliferating cells.Figure 3Loss in *Sox10* Negatively Impacts Exocrine Gland Formation(A) Confocal pictures of KIT, SOX10, and CCND1 co-staining in E13 and E16 SMG endbuds. Scale bars, 20 μm. Graph represents KIT^+^ subpopulations counted on multiple sections through endbuds at each time point. N \> 3, Mean ± SEM.(B and C) Bright-field and confocal pictures of E13 (B) and E14 (C) control (*Krt14*-Cre;*Rosa2*6-mTmG;*Sox10*^*flox/+*^ or *Rosa2*6-mTmG or *Sox10*^*flox/flox*^ mice) and *Sox10*^*fl/fl*^ (*Krt14*-Cre;*Rosa2*6-mTmG;*Sox10*^*flox/flox*^) SMGs. SMGs were labeled for SOX10, TUBB3, and CDH1. Scale bars, 100 and 20 μm.(D) Bright-field and fluorescent images of E16 control and *Sox10*^*fl/fl*^ SMGs. SMGs were stained for SOX10. Scale bars, 500 and 250 μm.(E) Quantification of endbud number in E13.5 and E14 SMGs from control and *Sox10*^*fl/fl*^ mice. Mean ± SEM, N \> 3, unpaired t test. ^∗^p \< 0.05, ^∗∗∗∗^p \< 0.0001. Control E13 (4.5 ± 0.4) versus *Sox10*^*fl/fl*^ (3.4 ± 0.2), control E14 (34.2 ± 2.8) versus *Sox10*^*fl/fl*^ (22.7 ± 2.4). Graph depicting GFP expression in E16 control and *Sox10*^*fl/fl*^ SMGs. Data are normalized to control, mean ± SEM, N \> 3, unpaired t test. ^∗^p \< 0.05. Control (100.0% ± 15.8%) versus *Sox10*^*fl/fl*^ (43.1 ± 7.2%).

To determine the function of *Sox10* during organ formation, we analyzed glands from *Sox10*^*flox/flox*^ mice crossed with epithelial-specific *Krt14*-Cre (referred as *Sox10*^*fl/fl*^) and/or *Rosa2*6-mTmG mice ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Fetal (E13, E14, and E16) SMGs were evaluated for mGFP and loss of SOX10 ([Figures 3](#fig3){ref-type="fig"}B--3D and [S3](#mmc1){ref-type="supplementary-material"}C). Non-epithelial cells remained mTomato^+^, and, as expected, SOX10 was only detected in TUBB3^+^ neuronal cells ([Figure 3](#fig3){ref-type="fig"}C). These data suggested that the *Krt14*-Cre;*Sox10*^*fl/fl*^ system specifically and efficiently targets epithelial *Sox10*.

We next measured the impact of *Sox10* loss on branching morphogenesis in SMG ([Figures 3](#fig3){ref-type="fig"}D and 3E). There was a significant reduction in endbud number at both E13.5 and E14 (40%), and 50% at E16 ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Notably, endbud counts becomes less accurate at E16; however, the remaining ductal tree structure became visible with reduced endbuds, as noticed in higher magnifications ([Figure 3](#fig3){ref-type="fig"}D). There was a 50% reduction in mGFP intensity in E16 *Krt14*-Cre;*Sox10*^*fl/lf*^;*mTmG* glands ([Figure 3](#fig3){ref-type="fig"}E), which reflected the reduction in epithelial size. This morphology was similar in post-natal SMGs ([Figure S3](#mmc1){ref-type="supplementary-material"}E). Similar impacts on organ formation of lacrimal, PAR, and SLG glands were observed, where distal branching and/or endbud numbers were significantly decreased ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). These data highlight that *Sox10* is necessary for proper organ formation induced by KIT^+^ endbud progenitors.

*Sox10* Is Essential for KIT^+^ Progenitor Maintenance and Differentiation into Secretory Units {#sec2.5}
-----------------------------------------------------------------------------------------------

To identify how *Sox10* influences progenitors, we performed protein and transcriptome profiling of known markers that define SMG progenitors in both control and *Sox10*^*fl/fl*^ E16 SMGs. Proliferating KIT^+^ progenitors are present in distal endbuds, but the remaining distal cells in *Sox10*^*fl/fl*^ SMGs did not show KIT and had reduced CCND1 ([Figures 4](#fig4){ref-type="fig"}A and 4B). While cell apoptosis occurs in developing organs as part of size expansion and differentiation ([@bib34]), no differences in cleaved caspase-3 were observed in epithelia or surrounding cells of *Sox10*^*fl/fl*^ SMGs ([Figure S4](#mmc1){ref-type="supplementary-material"}A). This suggests that *Sox10* directly affects KIT^+^ cell maintenance via proliferation. Alternatively, K14 and K5 expression, which mark basal and supra-basal duct cells that comprise a subpopulation of KIT^+^ cells ([@bib21]), were unaffected by *Sox10* loss, nor were their ductal K19^+^ and/or K7^+^ offspring or the *Wnt*/*Egfr*-related signaling pathway ([Figures 4](#fig4){ref-type="fig"}A and 4B). The expression of the KIT/FGFR2b signaling pathway ([@bib21]), including receptors *Kit* and *Fgfr1b* along with downstream targets *Etv5*, *Sox10*, and heparan sulfate ([Figure 4](#fig4){ref-type="fig"}B), were reduced in *Sox10*^*fl/fl*^ SMGs. In parallel, surface markers integrin alpha 6 (*Itga6*, *CD49f*), beta 1 (*Itgb1*, *CD29*), and CD24, which can enrich for adult SMG progenitors, remained unaltered, as did TF *Sox9* ([Figure S4](#mmc1){ref-type="supplementary-material"}B). SOX9 is expressed by distal and proximal cells in salivary and lacrimal glands, and is required for SOX10 expression ([@bib6], [@bib8]). In wild-type SMGs, *Sox9* is regulated by KIT/FGFR2b signaling, as stimulation of isolated E13 epithelia with FGF10 (F10) and/or KIT ligand (K) rapidly upregulated *Sox9* in 3 h ([Figure S4](#mmc1){ref-type="supplementary-material"}C), confirming the Chatzeli et al. study in which *Sox9* was absent in the SLG/SMG of *Fgf10*^*−/−*^ mice. Nonetheless, SOX9 protein expression remained present in basal epithelial and surrounding cell types in *Sox10*^*fl/fl*^ SMGs ([Figure S4](#mmc1){ref-type="supplementary-material"}D), suggesting that loss of *Sox10* and the subsequent reduction in KIT/FGFR2b signaling did not directly impact *Sox9*. Lastly, progenitors that form later in development were also evaluated. One progenitor population expressing the TF *Ascl3*, is detectable at E16 and is bipotent as it contributes to a subpopulation of adult SMG ductal and acinar cells ([@bib4]). To our surprise, *Ascl3* expression was upregulated in *Sox10*^*fl/fl*^ SMGs ([Figure S4](#mmc1){ref-type="supplementary-material"}B), which may be due to either decreased distal to proximal cell ratio or direct compensation in response to loss of *Sox10*. Overall, these data illustrate that *Sox10* is essential for the maintenance and proliferation of KIT^+^ progenitors.Figure 4*Sox10* Induces Plasticity By Regulating fetal KIT^+^ Progenitor Maintenance and Differentiation(A) Confocal imaging of control and *Sox10*^*fl/fl*^ E16 SMGs endbuds. Tissue was stained for KIT (arrow), CDH1, CCND1, K14, K5, K19, and/or K7. Scale bars, 20 μm.(B) Graphs show fold changes in gene expression of the *Fgfr2b*/*Kit* signaling pathway in epithelial (*Cdh1*) cells of *Sox10*^*fl/fl*^ E16 SMGs, *Ccnd1*, heparan sulfates, as well as ductal-related markers (*Krt*\'s) and correlated signaling pathways (*Egf*, *Wnt*). Data were normalized to *Rps29* and control (dotted line). Mean ± SEM, N \> 3, multiple comparison t test. ^∗^p \< 0.05.(C) Confocal imaging of stained E16 control and *Sox10*^*fl/fl*^ SMGs with ACTA2, AQP5, and K19. Arrow represents mislocated AQP5 expression in ducts. Scale bars, 20 μm.(D) Fold changes in gene expression of proteins expressed by myoepithelial, acinar, and/or ID cells. Data was normalized to *Rps29* and control (dotted line). Mean ± SEM, N \> 3, multiple comparison t test. ^∗^p \< 0.05. ^∗∗^p \< 0.01.(E) *Sox10*^*fl/fl*^ and control E16 SMGs were stained for SMGc, AQP5, K19, and DAPI and analyzed by confocal microscopy. Dotted line outlines the distal area. Scale bar, 20 μm.(F) RNA sequencing data of E16 *Sox10*^*fl/fl*^ SMGs versus control. The list of downregulated genes was generated after bioinformatic analysis of next-generation sequencing data and cutoff at log2 fold change (FC) of −0.25. Genes outlined in bold were validated by qPCR analysis.

The observation that E16 *Sox10*^*fl/fl*^ SMGs had aberrant morphology led us to hypothesize that *Sox10* affects differentiation. At E16, the differentiation of proacinar, intercalated duct, and myoepithelial cells begins, and continues up to post-natal day 20 ([@bib18]). The proacinar and intercalated duct cells both express AQP5 and are surrounded by an outer layer of myoepithelial cells ([Figure 4](#fig4){ref-type="fig"}C). This differentiation process only occurs in distal endbuds and not in the ducts. Consistent with our hypothesis, ACTA2 and AQP5 were absent in distally located cells of *Sox10*^*fl/fl*^ SMGs ([Figure 4](#fig4){ref-type="fig"}C). Moreover, acinar-specific secretory proteins, such as *Bpifa2* (parotid secretory protein, *Psp*), submandibular gland protein C (*Smgc*), and TF *Bhlha15* (Mist1) were downregulated ([Figures 4](#fig4){ref-type="fig"}D and 4E), illustrating a loss in initial differentiation of multiple cell types comprising the secretory unit of adult glands. Surprisingly, AQP5^+^ cells emerged proximally along the ducts of *Sox10*^*fl/fl*^ SMGs ([Figure 4](#fig4){ref-type="fig"}C), suggesting a potential compensation mechanism of the remaining *Sox10*^*fl/fl*^ ducts to differentiate into AQP5^+^ pro-acinar and/or intercalated duct (ID) cells.

Next, we performed RNA sequencing on E16 control and *Sox10*^*fl/fl*^ SMGs to identify molecular pathways related to *Sox10* in organ development. We obtained expression profiles from independent (N ≥ 3) biological samples and identified 81 genes that were downregulated more than −0.25 log2-fold change in *Sox10*^*fl/fl*^ SMGs ([Figures 4](#fig4){ref-type="fig"}F and [S4](#mmc1){ref-type="supplementary-material"}E). We used qPCR to validate *Sox10*, *Aqp5*, *Ccnd1*, *Bpifa2*, and *Acta2*. The set of downregulated genes were generally epithelial cell specific, as suggested by the mouse gene atlas network (Enrichr program \[[@bib7]\], [Figure S4](#mmc1){ref-type="supplementary-material"}F). Kyoto Encyclopedia of Genes and Genomes network pathway analysis identified downregulated genes as part of the vascular smooth muscle contraction, focal adhesion, and tight junction pathways ([Figure S4](#mmc1){ref-type="supplementary-material"}G). Genes in cGMP-PKG signaling reflect decreases in pathways using intracellular cGMP-dependent physiological processes that may show alterations of cytosolic calcium concentrations. Also associated with this is the neuropeptide oxytocin pathway, which is mediated via the oxytocin receptor, and exerts stimulation of milk release during lactation and myoepithelial contraction ([@bib9]). Other genes are related to the overall salivary secretion and hormone release/secretory protein synthesis, including prolactin signaling, mucin type O-glycan biosynthesis, glycolysis/gluconeogenesis, and insulin secretion. Overall, these results indicate a regulatory network by which *Sox10* stimulates KIT-dependent maintenance and their initiation toward multiple cell types of the secretory unit.

Non-SOX10^+^ Adult Duct Progenitors Fail to Initiate Proper Secretory Organ Function {#sec2.6}
------------------------------------------------------------------------------------

While the loss of *Sox10* during development reduced secretory unit differentiation, we predicted that post-natal salivary glands would also have reduced secretory function. A significant decrease was noticed in adult SMG size and weight in both sexes ([Figures 5](#fig5){ref-type="fig"}A and 5B and [S5](#mmc1){ref-type="supplementary-material"}A). Although the SLG weight was not affected, which is expected since its development has been shown to be SOX2 dependent ([@bib12]), we examined adult male and female SMGs via H&E staining, which showed disrupted cellular morphology. Acinar (Ac), ID, SD, and granular convoluted tubule cells are well defined in controls based on nuclear/cytoplasmic deposition, but their unique characteristics were not visible in *Sox10*^*fl/fl*^ SMGs ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}A). Cells became disorganized within the SMG, and some ductal structures were observed. The epithelial compartment of the adult SMG showed aberrant morphology, with an apparent increase in the amount of blood vessels (PECAM1, P1) and neuronal cells (TUBB3) ([Figure 5](#fig5){ref-type="fig"}D). mRNA analysis via qPCR confirmed increased trends of neuronal *Tubb3* and *Gfra2* ([Figure 5](#fig5){ref-type="fig"}E). Interestingly, changes in the mesenchymal and neuronal microenvironment were not noticeable during developmental stages E13 and E16 ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). The parasympathetic ganglia (TUBB3^+^) remained closely associated with the main duct, appeared similar in size, and innervated the endbuds similar to control. In addition, endothelial networks (PECAM1^+^) and stromal (*Cdh11*) cells appeared similar to control, suggesting that loss of the secretory units does not affect innervation or blood vessel formation.Figure 5*Sox10* Induces Plasticity by Regulating Fetal KIT^+^ Progenitor Maintenance and Differentiation(A) Bright-field picture of SMGs from female adult control or *Sox10*^*fl/fl*^ mice. Scale bar, 1 mm.(B) Graph represents weight of female SMGs as a percentage of body weight (bw) (control, 0.18% ± 0.01%; *Sox10*^*fl/fl*^, 0.13% ± 0.02%). Female SLG (control, 0.06% ± 0.01%; *Sox10*^*fl/fl*^, 0.07% ± 0.01%). Mean ± SEM, N \> 3, unpaired t test. ^∗∗∗^p \< 0.005.(C) H&E staining on paraffin sections of adult female SMGs of control or *Sox10*^*fl/fl*^ mice. Ac, ID, and SDs are outlined by white dotted line. Scale bar, 25 μm.(D) Confocal imaging of adult control and *Sox10*^*fl/fl*^ SMGs stained for CDH1, TUBB3, PECAM1 (P1), BHLHA15, K19, MUC10, AQP5, KIT, and CCND1. Scale bars, 20 μm.(E) qPCR analysis of genes comparing adult control and *Sox10*^*fl/fl*^ SMGs. Mean ± SEM, N \> 3, multiple comparison t test. ^∗∗∗^p \< 0.001, ^∗^p \< 0.05.(F) Saliva production of adult control and *Sox10*^*fl/fl*^ mice, normalized to their body weight. Mean ± SEM, N \> 3, unpaired t test. ^∗^p \< 0.05.(G) Secretory proteins from saliva of adult control and *Sox10*^*fl/fl*^ mice were separated using SDS-PAGE. Gels were stained with Coomassie blue.(H) MUC10 protein analysis in saliva of adult control and *Sox10*^*fl/fl*^ mice via western blot (WB). Graph shows quantification of MUC10 western using densitometry analysis. Mean ± SEM, N ≥ 3, unpaired t test. ^∗^p \> 0.05.

Next, we investigated the cell fate of remaining epithelial cells in adult *Sox10*^*fl/fl*^ SMGs. As predicted, *Sox10*^*fl/fl*^ SMGs had fewer secretory units and significantly more ducts (K19^+^, white dotted line) that were, surprisingly, surrounded by non-duct epithelia (CDH1^+^ K19^--^, yellow dotted line) ([Figure 5](#fig5){ref-type="fig"}D). However, only a few of the non-ductal epithelial cells expressed adult acinar-specific TF BHLHA15 (MIST1), AQP5, and/or secretory mucin protein MUC10 ([Figures 5](#fig5){ref-type="fig"}D and 5E). Interestingly, while the overall protein expression of AQP5 decreased ([Figure 5](#fig5){ref-type="fig"}D), its specific apical expression on the cells was reduced and the membrane localization remained limited only to the lateral border ([Figure S5](#mmc1){ref-type="supplementary-material"}D). The absence of apical AQP5, as seen in control SMGs ([@bib18]), would be predicted to reduce fluid secretion. In addition, using qPCR, there was a reduction in the mRNA expression of other secretory proteins observed that are produced by acinar cells, including Secretoglobin b1b27 (*Scgb1b27*, *Abpa*), amylase-1 (*Amy1*), prolactin-induced protein (*Pip*), and surfactant-associated protein C (*Sftpc*) ([Figure 5](#fig5){ref-type="fig"}E).

Importantly, adult epithelial cells that did not fully differentiate into secretory unit cells were confirmed to be the progeny of *Krt14*-Cre;*Sox10*^*flox/flox*^ cells, as all adult epithelia expressed mGFP ([Figure S5](#mmc1){ref-type="supplementary-material"}E). To outline ID cells, we analyzed KIT expression. Typical KIT^+^ ID cells were absent in *Sox10*^*fl/fl*^ SMGs, and overall proliferation (*Ccnd1*) was reduced ([Figure 5](#fig5){ref-type="fig"}D). In contrast, myoepithelial cells co-expressing ACTA2, K14, and K5 were more abundant in *Sox10*^*fl/fl*^ SMGs, surrounding the prominent ductal compartment ([Figure S5](#mmc1){ref-type="supplementary-material"}F). Interestingly, these data suggest that non-*Sox10* duct cells also have the potential to form myoepithelial cells in the absence of KIT^+^SOX10^+^ progenitors, suggesting a second source of myoepithelial progenitors.

To confirm the secretory deficiency of the *Sox10*^*fl/fl*^ SMGs, we measured total saliva production after pilocarpine stimulation, which includes secretions from SMG, PAR, and SLGs. We measured ∼50% reduction in saliva, likely reflecting reduced PAR and SMG function, since the SLGs appeared unaffected by loss of *Sox10* ([Figure 5](#fig5){ref-type="fig"}F, N ≥ 4). Subsequently, protein analysis of the saliva by SDS-PAGE and Coomassie staining highlighted that there are quantitative differences in salivary proteins (e.g., AMY1), as well as in low-molecular-weight proteins ([Figure 5](#fig5){ref-type="fig"}G, red box). Western blot analysis of an acinar-specific mucin, MUC10, confirmed its loss in saliva ([Figure 5](#fig5){ref-type="fig"}H). Overall, these observations suggest that the remaining non-*Sox10* duct cells attempt to compensate for the loss in secretory unit formation. However, in the adult environment the duct cells cannot alter their fate to form functional secretory units, which reduces organ function.

In a similar manner, the MMGs of lactating *Sox10*^*fl/fl*^ mice were smaller and showed white discoloration ([Figure S5](#mmc1){ref-type="supplementary-material"}G). Morphologically, *Sox10*^*fl/fl*^ MMGs showed few to no secretory units, which normally consist of ductal (KRT8^+^CDH1^+^), alveolar (KRT8^−^CDH1^+^), and myoepithelial (ACTA2^+^) cells. In addition, pups from *Sox10*^*fl/fl*^ mice did not survive the first 24 h post-birth unless fostered by control mice, confirming the inability of MMGs in adult *Sox10*^*fl/fl*^ mice to properly produce milk.

Overall, these data indicate that the effects of SOX10 loss affect multiple branching organs in their secretory function.

Expression of *Sox10* Increases Plasticity of Ductal Cells and Drives KIT^+^ Progenitor Formation {#sec2.7}
-------------------------------------------------------------------------------------------------

In complementary *in vitro* and *ex vivo* experiments, we used virus-mediated overexpression of *Sox10* in a mouse and human cell line and in primary mouse fetal cells as proof-of-principle experiments to determine *Sox10*'s capacity to alter the cell fate in non-KIT duct cells. We first transfected mouse salivary gland epithelial duct (SIMS) and human adult MMG luminal duct (MCF10A) cell lines. Cells were transduced with lentivirus particles expressing *Sox10* with human influenza hemagglutinin tag (*Sox10-HA*), a mutated *Sox10* that did not generate SOX10 protein ([Figure S6](#mmc1){ref-type="supplementary-material"}A) and/or CMV-*mCherry*. There was ∼97% infection efficiency, which was confirmed on protein level after transduction with the SOX10^+^-mCherry^+^ vector, the empty-CMV-*mCherry* vector, or the mutated *Sox10*-CMV-mCherry vector by immunofluorescence and western blot quantification ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C). The mCherry fluorescence was enhanced by RFP staining, which detected all mCherry^+^ cells ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Interestingly, after transduction with *Sox10* there was a significant increased gene expression of *Kit* in MCF10A and SIMS cells ([Figures 6](#fig6){ref-type="fig"}A and 6B). *Ffgr2b* was significantly upregulated in MCF10A and showed an increased trend in SIMS, as well as its downstream target *Etv4*. However, genes related to differentiation, such as *Acta2*, *Aqp5*, and/or *Amy1* remained unaltered during the limited time of passaging. Thus, in a minimal environment of 2D epithelial cell culture, *Sox10* expression can induce KIT^+^FGFR2b^+^SOX10^+^ cell-like type in adult ductal cells.Figure 6*Sox10* Induces Plasticity by Regulating Fetal KIT^+^ Progenitor Self-Renewal and Differentiation(A and B) Fold changes in gene expression of SIMS and MCF10A transduced with lentivirus-expressing *Sox10*, grown in 2D. Data were normalized to empty lentivirus-transduced cells and *Rps29* (dotted line). Mean ± SEM, N \> 3, multiple comparison t test. ^∗^p \< 0.05. ^∗∗^p \< 0.01.(C) Bright-field pictures of SIMS-*empty* or SIMS-*Sox10* in 3D, and cultured for 7 days in SIMS medium or differentiation (diff) medium. Scale bar, 250 μm.(D) Confocal images of K19, ACTA2, and CD166 on cells in the various conditions seen in (C). Scale bars, 30 μm.(E) Bright-field pictures of recombined fetal SMGs. Control or *Sox10*^*fl/fl*^ SMG E13 epithelia was transfected with control eGFP-Adv (C-Adv) or *Sox10*-Adv (S-Adv) at 0.005 or 50 MOI before being recombined with its original mesenchyme, blood vessels, and parasympathetic ganglia. Recombined glands were cultured for an additional 6 days. Tissue was stained for ACTA2, AQP5, K19, or SMGc, and analyzed by confocal microscopy. Scale bars, 20 μm.(F) Fold changes in expression of *Sox10*, and genes related to *Fgfr2b*/*Kit* signaling, myoepithelial, acinar, and ID markers from tissue in (E). Data were normalized to *Rps29* and C-Adv recombined tissue. Mean ± SEM, N \> 3, multiple comparison t test. ^∗^p \< 0.05.

As proper secretory unit formation may require 3D settings, we placed SIMS-*empty* or SIMS-*Sox10* cells in 3D. We used SIMS medium, as used in 2D, or differentiation medium, to stimulate secretory unit formation ([Figures 6](#fig6){ref-type="fig"}C, 6D, [S6](#mmc1){ref-type="supplementary-material"}D, and S6E). By 7 days in SIMS medium, SIMS-*empty* cells showed branched structures containing K19^+^ duct cells and cells expressing CD116, a marker for adult acinar cells ([@bib26]). In contrast, SIMS-*Sox10* cells formed round spheroids consisting of cells with low protein expression of K19, ACTA2, or CD166, suggesting that *Sox10* prevents differentiation. However, the opposite outcome was observed in differentiation medium. SIMS-*empty* cells grew as round spheroids with cells expressing low levels of K19, ACTA, and CD166, whereas SIMS-*Sox10* cells formed organoid-like structures with K19^+^ ductal, ACTA2^+^ myoepithelial, and CD166^+^ acinar cells. Thus, while SOX10^-^ SIMS-*empty* cells are able to form ducts and/or acini in 3D, overexpression of *Sox10* enables either cell maintenance or enhances differentiation into all secretory unit cell types. Moreover, this *Sox10*-driven cell fate decision seems to be dictated by different growth factors.

To evaluate whether *Sox10* alone can induce plasticity of fetal KIT^+^SOX10-primary duct cells, we enzymatically isolated E13 epithelia of control and *Sox10*^*fl/fl*^ SMGs and transduced them with adenovirus (Adv)-expressing mouse *Sox10*. The fetal SMG is easily dissociated into epithelium and mesenchyme, which is the endogenous fetal microenvironment containing stromal, endothelial, and neuronal cells. These compartments can be genetically manipulated with viral vectors before they get recombined and cultured further. Adv-*eGFP* was used as a control to show the high transduction efficiency of Adv in SMG epithelia ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Consequently, transduced epithelia were recombined with mesenchyme and cultured *ex vivo* for 6 days to reach an E16 SMG equivalent stage, as determined by the expression of cellular differentiation markers of myoepithelial, Ac, and ID cells ([Figure S6](#mmc1){ref-type="supplementary-material"}G). Recombined *Sox10*^*fl/fl*^ SMGs treated with control Adv had a ductal morphology, while *Sox10*-Adv treated explants formed prominent endbuds ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}H). Two different doses of Adv were used; MOI 0.005 and 50. Both MOIs resulted in increased expression of *Sox10* ∼20--40-fold, and qPCR analysis also showed increased expression of *Kit*, *Etv5*, *Aqp5*, *Smgc*, and *Bhlha15* ([Figure 6](#fig6){ref-type="fig"}F). Thus, gene expression changes suggested there was increased secretory unit differentiation with *Sox10* overexpression. Immunostaining highlighted a striking change in endbud morphology. There was a reappearance of distally located ACTA2^+^ myoepithelial, AQP5^+^ acinar/ID cells, and SMGc^+^ acinar cells ([Figure 6](#fig6){ref-type="fig"}E), which confirmed that *Sox10* is sufficient to induce cell fate changes in fetal non-KIT duct cells and regain the characteristics of multi-potent KIT^+^SOX10^+^ progenitors in a normal developing environment.

Overall, these data indicate that expression of the TF *Sox10* can induce plasticity to form KIT^+^SOX10^+^ progenitors in adult epithelial duct cells. Moreover, in 3D *ex vivo* settings, *Sox10* expression increases the plasticity of non-SOX10 expressing duct cells to either induce maintenance or differentiation into secretory units.

Discussion {#sec3}
==========

Our studies have identified an essential role for *Sox10* in the formation of multi-potent progenitors within multiple exocrine glands. First, *Sox10* is essential for the maintenance and proliferation of KIT^+^ progenitors. An additional role of *Sox10* is to initiate the differentiation of KIT^+^ progenitors toward myoepithelial, acinar, and ID cells, all of which form the secretory unit of exocrine glandular tissues. Lastly, we show that *Sox10* expression can alter the plasticity of non-KIT epithelial cells by driving their cell fate toward a multi-potent KIT^+^ progenitor; all which indicate that SOX10 is a universal master regulator in exocrine glands.

There are striking similarities in the role of *Sox10* in multiple exocrine glands. Our initial findings that *Sox10* is regulated by KIT/FGFR2b signaling ([@bib21]) was later, in part, confirmed in both lacrimal and MMGs ([@bib8], [@bib11]), in which FGF10/FGFR2b activation or loss influenced *Sox10* expression. We show that KIT and SOX10 are present in distal lacrimal gland endbuds. Similarly, both SOX10 and KIT expression were correlated with mammary epithelial progenitors ([@bib11], [@bib29]).

Also, *in vitro* mammary spheroid assays determined that SOX10^+^ stem/progenitors were three times more potent than the classical CD24^hi^CD49f^+^ cells, which long defined MMG stem cells ([@bib11]). In addition, SOX10^+^ tumors from both salivary ([@bib27]) and MMGs ([@bib13]) show characteristics of acinar, ID, and/or myoepithelial cells. Together with our data showing that SOX10 marks multi-potent progenitors during the initiation of lacrimal and salivary glands, we conclude that *Sox10* is a master regulator of secretory unit differentiation in multiple exocrine glands.

The function of *Sox10* correlates to its expression levels ([@bib11]). For example, ectopic *Sox10* overexpression in isolated primary mammary organoids results in a mesenchymal-like phenotype. The high expressing *Sox10* cells failed to organize into secondary organoids, whereas lower *Sox10* levels enabled the formation of secondary organoids. In contrast, our ectopic expression experiments were performed by *ex vivo* recombination assays allowing the *Sox10*-transduced epithelium to interact with its endogenous multi-cell fetal microenvironment. We concluded that *Sox10* expression drives the formation of the KIT^+^SOX10^+^ progenitor state, which can differentiate into multiple cell types. Even at high *Sox10* expression levels, myoepithelial cell differentiation occurs, which involves an epithelial-mesenchymal transition in glandular tissues ([@bib37]). Myoepithelial cells in the MMG share a transcriptional profile with a breast cancer subtype, which was proposed to derive from a highly migratory myoepithelial progenitor ([@bib37]). These data are thus not contradictory with our results, as plasticity is defined by both cell-autonomous and non-cell-autonomous settings. The microenvironment therefore plays a critical role in the level to which plasticity is induced. Both studies cultured mammary myoepithelial progenitors or *Sox10*-expressing epithelial cells in Matrigel, a basement membrane extract, which resulted in loss of polarization and elevated migratory properties. Our data show how *Sox10* overexpression in non-*Sox10* fetal epithelial cells cultured in their endogenous multi-cell-type fetal microenvironment results in epithelial differentiation. This endogenous 3D fetal tissue microenvironment is as important to direct cell plasticity as the intracellular master regulator(s). Secreted factors from other cell types may be required in combination with *Sox10* to induce plasticity and direct the various cell lineages in normal, deprived, diseased, or injured environments. This idea is supported by the fact that *Sox10* overexpression in adult duct cells in 2D induced plasticity toward a KIT-like cell, but drove maintenance or differentiation in 3D settings. However, we speculate that *Sox10* might need additional master regulators to induce plasticity in cells that are of a more distant cell lineage.

An interesting finding in our study was the inability of remaining epithelial duct cells in *Sox10*^*fl/fl*^ SMGs to differentiate into functional secretory units. Multiple progenitors have been identified that participate during salivary gland development. At various time-points during organogenesis multi-potent and more restricted progenitors are formed. One late-stage bipotent progenitor expressing TF *Ascl3* is detected in the SMG at E16. From lineage-tracing studies, *Ascl3* cells give rise to some, but not all, adult ductal and mucous-secreting acinar cells ([@bib4]). Ablation of *Ascl3* cells did not reveal any impact on glandular formation, likely due to compensation of other progenitors present ([@bib2]). In contrast, loss of KIT progenitors by reducing *Sox10* had a great impact on gland morphology. Surprisingly, higher *Ascl3* expression was observed at E16. Yet, *Ascl3*-expressing cells and/or other non-KIT progenitors were not sufficient to produce fully functional secretory units. Interestingly, myoepithelial cell formation did occur from non-KIT duct progenitors, which supports a novel concept that myoepithelial cells can arise from two independent cell sources; KIT^+^ progenitors and non-KIT progenitors.

Another issue requiring further investigation is whether an altered microenvironment is created after loss of KIT^+^ progenitors and their immediate progeny post-E16. Multi-cell-type crosstalk occurs between glandular epithelial progenitors, neuronal, stromal, and endothelial cells ([@bib16], [@bib25]). It is possible that the absence of KIT^+^ progenitors and their progeny affects paracrine signals that influence blood vessel and neuronal cell formation. The control of secretory function in adult tissues is dependent on innervation. Whether lack of secretory units influences the amount or type of innervation remains to be investigated. It also remains to be tested whether SOX10^--^ duct cells can form mature acinar cells postnatally in a SOX10-independent manner. Similarly, it still needs to be determined whether SOX10 regulates the expression of *Kit* and *Fgfr2b* directly or indirectly. At a minimum, our data suggest that SOX10 plays a role in the positive feedback loop of KIT/FGFR2b signaling.

In conclusion, our results suggest that *Sox10* is a master regulator in epithelial KIT^+^ progenitors of exocrine glands, including lacrimal, salivary, and MMGs, thus making it a potential target to induce secretory unit formation for *in vitro* glandular tissue engineering purposes and/or regenerative strategies.

Experimental Procedures {#sec4}
=======================

Animal Care and Use {#sec4.1}
-------------------

All experiments were approved by the animal care and use committees at the University of Michigan and the National Institute of Dental and Craniofacial Research at the NIH. More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

*Ex Vivo* Organ Culture, Recombination Assays, and Adenovirus Transduction {#sec4.2}
--------------------------------------------------------------------------

Isolation of fetal tissue, epithelial dissection, fetal tissue culture, growth factor concentrations, and recombination assays were described previously ([@bib21]). More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Immunohistochemistry/Fluorescence {#sec4.3}
---------------------------------

Fetal tissue was fixed, blocked, stained, and labeled with primary antibodies according to previously described protocols ([@bib21]). More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

qPCR {#sec4.4}
----

Real-time PCR was performed as described previously ([@bib21]). More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Saliva Collection {#sec4.5}
-----------------

Animals were placed in a restraining device 5 min after pilocarpine injection (2.5 mg/kg, subcutaneously). Saliva was then collected for 15 min and quantified as a volume to body weight ratio, as outlined in ([@bib22]). More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Western Blot Analysis and Coomassie Staining {#sec4.6}
--------------------------------------------

Protein from saliva was quantified with a BCA test, and resolved on Bis-Tris gels. More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

RNA Sequencing and Bioinformatics Analysis {#sec4.7}
------------------------------------------

Total RNA was extracted from E16 SMGs using the Ambion microRNA kit. More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Lentiviral Overexpression and 3D Culture {#sec4.8}
----------------------------------------

SIMS and MCF10a cells were cultured and grown in their respective growth media ([@bib17], [@bib28]). More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis and Data Availability {#sec4.9}
------------------------------------------

Statistical parameters included N ≥ 3. More information is given in the [Supplemental Information](#mmc1){ref-type="supplementary-material"}.
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